We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+48.29%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$355M
AUM Growth
+$129M
(+57%)
Cap. Flow
+$44.7M
Cap. Flow
% of AUM
12.6%
Top 10 Holdings %
Top 10 Hldgs %
99.41%
Holding
11
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
PETX
Aratana Therapeutics, Inc.
PETX
|
+$43.8M |
| 2 |
HSTO
Histogen Inc. Common Stock
HSTO
|
+$11.1M |
Top Sells
| 1 |
Verastem
VSTM
|
+$10.2M |
Sector Composition
| 1 | Healthcare | 56.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $115M | 32.49% |
2,880,485
| – | – |
|
|
PETX
2
DELISTED
Aratana Therapeutics, Inc.
PETX
| $71.1M | 20.05% |
4,351,048
+4,170,543
| +2,310% | +$43.8M |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $65.3M | 18.41% |
2,441,344
| – | – |
|
4
Pacira BioSciences
PCRX
$1.01B
| $39.6M | 11.17% |
824,255
| – | – |
|
5
Altimmune
ALT
$554M
| $13.3M | 3.76% |
21,159
| – | – |
|
|
6
Verastem
VSTM
$507M
| $12.9M | 3.63% |
86,110
-58,571
| -40% | -$10.2M |
|
|
HSTO
7
DELISTED
Histogen Inc. Common Stock
HSTO
| $12M | 3.38% |
+5,960
| New | +$11.1M |
|
|
KBIO
8
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $11.9M | 3.36% |
329,116
| – | – |
|
|
ZLCS
9
DELISTED
ZALICUS INC COM NEW
ZLCS
| $6.68M | 1.88% |
927,830
| – | – |
|
|
AVEO
10
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $4.55M | 1.28% |
220,896
| – | – |
|
|
ETRM
11
DELISTED
EnteroMedics Inc.
ETRM
| $2.09M | 0.59% |
1,590
| – | – |
|
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM